Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of multiple oral doses of S44121 in chronic heart failure with left ventricular dysfunction
2009-011558-16Phase 2Completed
- Sponsor
- Servier
- Start
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of S44121 in chronic heart failure (CHF) and left ventricular systolic dysfunction (LVSD) (5 arms), sponsored by Servier. Primary endpoints: Echocardiographic parameters and NT-proBNP levels. Started Jan 2010; status: completed.
02
Drugs
S44121
03
Conditions
chronic heart failure (CHF)left ventricular systolic dysfunction (LVSD)
Beyond the preview
Go deeper on 2009-011558-16.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-011558-16.